KUVATRIS THERAPEUTICS, INC. Stock-Based Compensation
KUVATRIS THERAPEUTICS, INC. reported Stock-Based Compensation of $1.51 million for the 9-month period ending 2024-09-30, per its 10-Q filed 2026-01-14.
Financial Statements › Cash Flow › Operating Activities
us-gaap:ShareBasedCompensation · last filed 2026-01-14
- KUVATRIS THERAPEUTICS, INC. share-based payment arrangement, noncash expense for the quarter ending 2024-09-30 was $0.00, a 100.00% decline year-over-year.
- KUVATRIS THERAPEUTICS, INC. share-based payment arrangement, noncash expense for the quarter ending 2024-06-30 was $151.00, a 99.99% decline year-over-year.
- KUVATRIS THERAPEUTICS, INC. share-based payment arrangement, noncash expense for the quarter ending 2024-03-31 was $1.51M, a 30.28% decline year-over-year.
- KUVATRIS THERAPEUTICS, INC. share-based payment arrangement, noncash expense for the quarter ending 2023-12-31 was $704.77K, a 76.82% decline year-over-year.
- KUVATRIS THERAPEUTICS, INC. share-based payment arrangement, noncash expense for fiscal 2023 was $5.20M, a 17.81% increase from fiscal 2022.
- KUVATRIS THERAPEUTICS, INC. share-based payment arrangement, noncash expense for fiscal 2022 was $4.42M, a 230.73% increase from fiscal 2021.
- KUVATRIS THERAPEUTICS, INC. share-based payment arrangement, noncash expense for fiscal 2021 was $1.34M.
| Period end | Share-based Payment Arrangement, Noncash Expense 3 month | Share-based Payment Arrangement, Noncash Expense 6 month | Share-based Payment Arrangement, Noncash Expense 9 month | Share-based Payment Arrangement, Noncash Expense 12 month |
|---|---|---|---|---|
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2026-01-14 | $151.00 derived: sum of 2 quarters · filed 2026-01-14 | $1.51M 10-Q · filed 2026-01-14 | $2.22M derived: sum of 4 quarters · filed 2026-01-14 |
| 2024-06-30 | $151.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-09-20 | $1.51M 10-Q · filed 2024-09-20 | $2.22M derived: sum of 3 quarters · filed 2024-09-20 | $3.28M derived: sum of 4 quarters · filed 2026-01-14 |
| 2024-03-31 | $1.51M 10-Q · filed 2024-05-13 | $2.22M derived: sum of 2 quarters · filed 2024-05-13 | $3.28M derived: sum of 3 quarters · filed 2026-01-14 | $4.55M derived: sum of 4 quarters · filed 2026-01-14 |
| 2023-12-31 | $704.77K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-11 | $1.77M derived: sum of 2 quarters · filed 2026-01-14 | $3.03M derived: sum of 3 quarters · filed 2026-01-14 | $5.20M 10-K · filed 2024-03-11 |
| 2023-09-30 | $1.06M derived: 10-Q 9 month − 10-Q 6 month · filed 2026-01-14 | $2.33M derived: sum of 2 quarters · filed 2026-01-14 | $4.50M 10-Q · filed 2026-01-14 | $7.54M derived: sum of 4 quarters · filed 2026-01-14 |
| 2023-06-30 | $1.26M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-09-20 | $3.44M 10-Q · filed 2024-09-20 | $6.48M derived: sum of 3 quarters · filed 2024-09-20 | $7.52M derived: sum of 4 quarters · filed 2024-09-20 |
| 2023-03-31 | $2.17M 10-Q · filed 2024-05-13 | $5.21M derived: sum of 2 quarters · filed 2024-05-13 | $6.26M derived: sum of 3 quarters · filed 2024-05-13 | $6.41M derived: sum of 4 quarters · filed 2024-05-13 |
| 2022-12-31 | $3.04M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-11 | $4.09M derived: sum of 2 quarters · filed 2024-03-11 | $4.24M derived: sum of 3 quarters · filed 2024-03-11 | $4.42M 10-K · filed 2024-03-11 |
| 2022-09-30 | $1.05M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-16 | $1.20M derived: sum of 2 quarters · filed 2023-11-16 | $1.38M 10-Q · filed 2023-11-16 | $1.60M derived: sum of 4 quarters · filed 2023-11-16 |
| 2022-06-30 | $148.82K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | $330.01K 10-Q · filed 2023-08-09 | $555.00K derived: sum of 3 quarters · filed 2023-08-09 | $827.13K derived: sum of 4 quarters · filed 2023-08-09 |
| 2022-03-31 | $181.19K 10-Q · filed 2023-05-15 | $406.19K derived: sum of 2 quarters · filed 2023-05-15 | $678.31K derived: sum of 3 quarters · filed 2023-05-15 | |
| 2021-12-31 | $224.99K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | $497.12K derived: sum of 2 quarters · filed 2023-03-30 | $1.34M 10-K · filed 2023-03-30 | |
| 2021-09-30 | $272.12K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $1.11M 10-Q · filed 2022-11-14 | ||
| 2021-06-30 | $838.75K 10-Q · filed 2022-09-30 |